Cargando…

Comparative Efficacy of Oral Chinese Patent Medicine for Chronic Prostatitis/Chronic Pelvic Pain Syndrome With Sexual Dysfunction: A Bayesian Network Meta-Analysis of Randomized Controlled Trials

Background: Oral Chinese patent medicine (OCPM) combined with western medicine (WM) are believed to be effective for the therapy of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) with sexual dysfunction (SD). These western medicines mainly involve antibiotics, phosphodiesterase type-5 in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yang, Ma, Hongzhao, Nan, Tao, Li, Yongqiang, Zheng, Wei, Zhou, Zhihui, Gong, Xiaoyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143435/ https://www.ncbi.nlm.nih.gov/pubmed/34040523 http://dx.doi.org/10.3389/fphar.2021.649470

Ejemplares similares

Traditional Chinese medicine on treating chronic prostatitis/chronic pelvic pain syndrome: A systematic review and meta-analysis
por: Xue, Yahui, et al.
Publicado: (2019)

Effectiveness comparisons of acupuncture for chronic prostatitis/chronic pelvic pain syndrome: A Bayesian network meta-analysis protocol
por: Lei, Yi, et al.
Publicado: (2019)

Prevalence of sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome: a meta-analysis
por: Li, Hong-Jun, et al.
Publicado: (2015)

Ningmitai capsules have anti-inflammatory and pain-relieving effects in the chronic prostatitis/chronic pelvic pain syndrome mouse model through systemic immunity
por: Liu, Hanchao, et al.
Publicado: (2022)

Chinese Patent Medicines in the Treatment of Coronavirus Disease 2019 (COVID-19) in China
por: Zhuang, Wei, et al.
Publicado: (2020)

Potential Mechanisms of Action of Chinese Patent Medicines for COVID-19: A Review
por: Yang, Zhi-Hua, et al.
Publicado: (2021)

AB271. Sexual dysfunction in chronic prostatitis
por: Cho, In-Rae
Publicado: (2016)

Corrigendum: Potential Mechanisms of Action of Chinese Patent Medicines for COVID-19: A Review
por: Yang, Zhi-Hua, et al.
Publicado: (2021)

Saikosaponin D Rescues Deficits in Sexual Behavior and Ameliorates Neurological Dysfunction in Mice Exposed to Chronic Mild Stress
por: Wang, Zhuo, et al.
Publicado: (2021)

Efficacy and Safety of Chinese Patent Medicine for the Prevention and Treatment of Radiotherapy and Chemotherapy-Induced Oral Mucositis: A Systematic Review and Meta-Analysis
por: Xie, Yufei, et al.
Publicado: (2022)

Is mild erectile dysfunction associated with severe psychological symptoms in Chinese patients with moderate-to-severe chronic prostatitis/chronic pelvic pain syndrome?
por: Li, Xiu-Cheng, et al.
Publicado: (2020)

Accumulation of Arsenic Speciation and In Vivo Toxicity Following Oral Administration of a Chinese Patent Medicine Xiao-Er-Zhi-Bao-Wan in Rats
por: Luo, Jiaoyang, et al.
Publicado: (2017)

Uncovering the genetic links of diabetic erectile dysfunction and chronic prostatitis/chronic pelvic pain syndrome
por: Yuan, Penghui, et al.
Publicado: (2023)

A Retrospective Study on the Use of Chinese Patent Medicine in 24 Medical Institutions for COVID-19 in China
por: Zhang, Nan, et al.
Publicado: (2020)

The comparative effects of oral Chinese patent medicines combined with western medicine in stable angina: A systematic review and network meta-analysis of 179 trials
por: Huang, Peiying, et al.
Publicado: (2022)

Clinical Progress on Management of Pneumonia Due to COVID-19 With Chinese Traditional Patent Medicines
por: Wu, Ying, et al.
Publicado: (2021)

Traditional Chinese Medicine Oral Liquids Combined With Azithromycin for Mycoplasma pneumoniae Pneumonia in Children: A Bayesian Network Meta-Analysis
por: Chen, Zhe, et al.
Publicado: (2021)

Is chronic prostatitis/chronic pelvic pain syndrome an infectious disease of the prostate?
por: Nickel, J. Curtis
Publicado: (2017)

Corpus cavernosum smooth muscle cell dysfunction and phenotype transformation are related to erectile dysfunction in prostatitis rats with chronic prostatitis/chronic pelvic pain syndrome
por: Wang, Guang-chun, et al.
Publicado: (2020)

Efficacy and Safety of Oral Acetaminophen for Premature Infants With Patent Ductus Arteriosus: A Meta-Analysis
por: Zi-Yun, Xie, et al.
Publicado: (2022)

Insights of Chinese herbal medicine for mitochondrial dysfunction in chronic cerebral hypoperfusion induced cognitive impairment: Existed evidences and potential directions
por: Wang, Yefei, et al.
Publicado: (2023)

The Lifetime Risk and Prognosis of Chronic Prostatitis/Chronic Pelvic Pain Syndrome in the Middle-Aged Chinese Males
por: Zhang, Jianzhong, et al.
Publicado: (2019)

Efficacy and Safety of Chinese Patent Medicine Combined With Oseltamivir in Treatment of Children With Influenza: A meta-Analysis
por: Duan, Nai-fan, et al.
Publicado: (2021)

Integrated Metabolomics and Network Pharmacology Study on the Mechanism of Kangfuxiaoyan Suppository for Treating Chronic Pelvic Inflammatory Disease
por: Zhang, Zhengyi, et al.
Publicado: (2022)

Erratum: A Retrospective Study on the Use of Chinese Patent Medicine in 24 Medical Institutions for COVID-19 in China
por: Frontiers Production Office,
Publicado: (2021)

Comparative efficacy of Chinese patent medicines for non-alcoholic fatty liver disease: A network meta-analysis
por: Zhang, Lihui, et al.
Publicado: (2023)

Neuroimaging Studies of Chronic Prostatitis/Chronic Pelvic Pain Syndrome
por: Zhao, Yifan, et al.
Publicado: (2022)

Chronic Prostatitis/Chronic Pain Pelvic Syndrome and Male Infertility
por: Graziani, Andrea, et al.
Publicado: (2023)

Immunological Mechanisms Underlying Chronic Pelvic Pain and Prostate Inflammation in Chronic Pelvic Pain Syndrome
por: Breser, María L., et al.
Publicado: (2017)

Once-daily 5 mg tadalafil oral treatment for patients with chronic prostatitis/chronic pelvic pain syndrome
por: Benelli, Andrea, et al.
Publicado: (2018)

TaqMan Probe-Based Quantitative Real-Time PCR to Detect Panax notoginseng in Traditional Chinese Patent Medicines
por: Lou, Qian, et al.
Publicado: (2022)

Treatment options of traditional Chinese patent medicines for dyslipidemia in patients with prediabetes: A systematic review and network meta-analysis
por: Jiang, Li, et al.
Publicado: (2022)

Effectiveness Comparisons of Drug Therapy on Chronic Subdural Hematoma Recurrence: A Bayesian Network Meta-Analysis and Systematic Review
por: Yu, Wanli, et al.
Publicado: (2022)

Mechanisms and Efficacy of Chinese Herbal Medicines in Chronic Kidney Disease
por: Zhao, Mingming, et al.
Publicado: (2021)

Chronic Pelvic Pain and Sexual Dysfunction Among Females and Males Receiving Treatment for Opioid Use Disorder
por: Reichmann, Geetika, et al.
Publicado: (2022)

Chronic Pelvic Pain in Endometriosis: Cross-Sectional Associations with Mental Disorders, Sexual Dysfunctions and Childhood Maltreatment
por: Netzl, Johanna, et al.
Publicado: (2022)

28-Day Oral Chronic Toxicity Study of Arctigenin in Rats
por: Tan, Yu-jun, et al.
Publicado: (2018)

Melatonin-related dysfunction in chronic restraint stress triggers sleep disorders in mice
por: Xia, Tian-Ji, et al.
Publicado: (2023)

An Efficacy and Feasibility Analysis of Chinese Patent Medicine Combined With Letrozole in the Treatment of Women With Ovulation Disorders: A Network Meta-Analysis
por: Zhu, Jing-Yan, et al.
Publicado: (2021)

Quantitative Determination and Toxicity Evaluation of Aristolochic Acid Analogues in Asarum heterotropoides F. Schmidt (Xixin) and Traditional Chinese Patent Medicines
por: Liu, Suyan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i8jv41fltgiba5d2eg4tmn1pjt